Concepedia

Joanne M. Donovan

JM

Statistics

Publications

29

Citations

2K

H-Index

23

Active since

1985

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Catabasis Pharmaceuticals (United States)

Eloxx Pharmaceuticals (United States)

Center for Clinical Research (United States)

Joanne M. Donovan is an author at Brigham and Women's Hospital specializing in pharmacology, biochemistry, and clinical pharmacology.

Publications per year

1985–2021

29

Publications

29

Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia

Evan A. Stein, Robert Dufour, Claude Gagné et al. · Circulation · 2012 · 300 citations

, , +17

Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia

Howard H Knapp, Helmut G. Schrott, Patrick Ma et al. · The American Journal of Medicine · 2001 · 203 citations

, , +13

Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers

Erik Eckhardt, David Q.‐H. Wang, Joanne M. Donovan et al. · Gastroenterology · 2002 · 196 citations · Full text

, , +17

Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial

Maartje E. Visser, Gilbert Wagener, Brenda F. Baker et al. · European Heart Journal · 2012 · 190 citations · Full text

, , +17

Effectiveness of Colesevelam Hydrochloride in Decreasing LDL Cholesterol in Patients With Primary Hypercholesterolemia: A 24-Week Randomized Controlled Trial

William Insull, Phillip D. Toth, William S. Mullican et al. · Mayo Clinic Proceedings · 2001 · 139 citations

, , +16

1–5 of 29